- Research works
- 25 ▲ 29% vs 2013–17
- Citations
- 433 17.4 per fractional work
- Top-10% rate
- 19.7% record average 16.5%
- Open access
- 55% world 28%
Not ranked overall: Evive Biotech (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.0×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 8.0×
- Immunology and Microbiology 5.9×
- Agricultural and Biological Sciences 2.2×
- Medicine 1.4×
- Health Professions 0.9×
- Environmental Science 0.7×
- Chemistry 0.6×
- Computer Science 0.3×
- Social Sciences 0.2×
- Materials Science 0.1×
- Engineering 0.1×
- Physics and Astronomy 0.1×
Which keywords describe research at Evive Biotech (China)?
By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Cancer, Genetic Mutations, Glycosylation, Chemotherapy, Antibody Engineering and Fc Receptors.
- Biopharmaceuticals
- Lymphoma
- Neutropenia
- Hematological Malignancies
- Congenital Disorders
- Fc Receptors
- Chemotherapy
- Genetic Mutations
- Therapeutic Antibodies
- Monoclonal Antibodies
- Cancer
- Glycosylation
- Antibody Engineering
- Antimicrobial Agents
- Febrile Neutropenia
- Hematopoietic Stem Cells
- Immunotherapy
- Inflammation
- Protein Aggregation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 19 words, with their numbers
- Monoclonal Antibodies3▲ 76×2 topics
- Therapeutic Antibodies3▲ 85×2 topics
- Cancer3▲ 7.5×10 topics
- Genetic Mutations2▲ 16×4 topics
- Glycosylation2▲ 37×2 topics
- Chemotherapy2▲ 10.0×5 topics
- Antibody Engineering2▲ 69×1 topic
- Fc Receptors2▲ 69×1 topic
- Antimicrobial Agents2▲ 349×1 topic
- Congenital Disorders2▲ 305×1 topic
- Febrile Neutropenia2▲ 349×1 topic
- Hematological Malignancies2▲ 178×2 topics
- Hematopoietic Stem Cells2▲ 65×2 topics
- Neutropenia2▲ 305×1 topic
- Immunotherapy1▲ 8.7×9 topics
- Lymphoma1▲ 31×2 topics
- Inflammation1▲ 1.89×9 topics
- Biopharmaceuticals1▲ 59×1 topic
- Protein Aggregation1▲ 51×1 topic
Which research topics does Evive Biotech (China) publish most on?
By volume in 2022–2025: Protein purification and stability, Monoclonal and Polyclonal Antibodies Research, Neutropenia and Cancer Infections and Blood disorders and treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Protein purification and stability Molecular Biology 1 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 3 Neutropenia and Cancer Infections Oncology 1 works
- 4 Blood disorders and treatments Genetics 1 works
- 5 Fungal Infections and Studies Epidemiology 0 works
- 6 Immune Response and Inflammation Immunology 0 works
- 7 vaccines and immunoinformatics approaches Molecular Biology 0 works
- 8 Plant Disease Resistance and Genetics Plant Science 0 works
- 9 Genetics and Plant Breeding Plant Science 0 works
- 10 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Evive Biotech (China)'s research output changed?
Output in 2018–2022 was 29% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Shanghai
- Shanghai Jiao Tong University
- Tongji University
- Fudan University
- Shanghai University
- East China Normal University
- East China University of Science and Technology
- Donghua University
- University of Shanghai for Science and Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.